Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...

Explore essential statistical strategies for accurate protein quantification and differential expression analysis.

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ ...

An incorrect Funding statement was provided. The correct Funding statement reads: “The author(s) declare that financial support was received for the research and/or publication of this article. This ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

[Image from the Vaxess website] Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver semaglutide. Semaglutide, a GLP-1 receptor ...